We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Samsung Bioepis Prevails in UK Patent Court Dispute Over AbbVie’s Humira
Samsung Bioepis Prevails in UK Patent Court Dispute Over AbbVie’s Humira
A UK patent court invalidated two of AbbVie’s Humira patents — clearing a major barrier for drugmakers seeking EU approvals for biosimilar versions of the blockbuster arthritis treatment.